That is the whole story, start to finish: a stubborn idea from 1975, a researcher who spent his life on it, a compound that healed everything in rats, a human trial whose result nobody saw for twenty years, a molecule no company can own so no company will finish testing, and a stack of the most basic questions is it safe, at what dose, made by whom, and how does it actually work that still have no answers
For example, some compounded GLP-1s may include Vitamin B12, which can help mitigate common side effects like nausea and boost energy
Tesofensine (The Traffic Controller): A triple monoamine reuptake inhibitor (SNDRI) that elevates serotonin, dopamine, and norepinephrine
A theoretical concern in research pertains to copper homeostasis: since GHK-Cu delivers copper ions, copper status should be monitored during extended research protocols
The experiment was terminated on day 124 post-injection based on humane endpoint considerations, and mice were sacrificed at this time point for subsequent analyses
The 2024 structural study in Cell Research examined receptor recognition across GLP-1R, GIPR, and GCGR and reported that triple agonism involves conserved interactions along with receptor-specific contacts in the transmembrane domain pocket